Aspire Biopharma Holdings Cash Flow Statement (2021-2026) | ASBP

Cash Flow Statement Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -0.00B-0.00B-0.02B-0.00B-0.01B-0.00B
Share-based Compensation (Quarter) 14,131.25B-14131.24B-0.00B0.00B
Cash from Operations (Quarter) -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.00B0.00B0.01B0.00B
Change in Working Capital
Change in Inventory (Quarter) 0.00B0.00B
Change in Account Payables (Quarter) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B-0.00B
Change in Accured Expenses (Quarter) -0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B0.00B-0.00B-0.00B0.00B-0.00B
Other Working Capital Changes (Quarter) 0.00B0.00B
Investing Activities
Cash from Investing Activities (Quarter) -0.29B0.00B
Financing Activities
Other financing activities (Quarter) 0.01B0.00B-1.00
Cash from Financing Activities (Quarter) 0.00B0.30B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B0.00B-0.00B0.01B
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 0.00B0.00B0.01B
Additional items
Change in Cash (Quarter) 0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-280.000.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B
Free Cash Flow (Quarter) -0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Net Cash Flow (Quarter) 0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-280.000.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B-0.00B0.00B